Last update 26 May 2025

Nitazoxanide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Colufase, Cryptaz, Daxon
+ [9]
Target
Action
inhibitors
Mechanism
PFOR inhibitors(Pyruvate synthase inhibitors)
Originator Organization
Active Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (22 Nov 2002),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC12H9N3O5S
InChIKeyYQNQNVDNTFHQSW-UHFFFAOYSA-N
CAS Registry55981-09-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cryptosporidiosis
United States
22 Nov 2002
Diarrhea
United States
22 Nov 2002
Giardiasis
United States
22 Nov 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Post Acute COVID 19 SyndromePhase 3
United States
13 May 2020
COVID-19Phase 3
United States
12 May 2020
Viral respiratory infectionPhase 3
United States
12 May 2020
Common ColdPhase 3
United States
11 Sep 2018
Common ColdPhase 3
Puerto Rico
11 Sep 2018
Enterovirus InfectionsPhase 3
United States
11 Sep 2018
Enterovirus InfectionsPhase 3
Puerto Rico
11 Sep 2018
Rhinovirus infectionPhase 3
United States
11 Sep 2018
Rhinovirus infectionPhase 3
Puerto Rico
11 Sep 2018
Influenza B virus infectionPhase 3
United States
01 Mar 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
214
Vitamin Super B-Complex+Nitazoxanide
(Nitazoxanide)
jkivbspcaw(rwpnjjcxuq) = fapwqbdaxz rcsijxthxw (jxfdlpdwls, bhvmvxzuff - tlucfmiyjc)
-
17 Oct 2024
Placebo
(Placebo)
jkivbspcaw(rwpnjjcxuq) = tsfollwkji rcsijxthxw (jxfdlpdwls, gxgtpdfoxk - ifgntkfmua)
Not Applicable
-
Levofloxacin, nitazoxanide, doxycycline, and lansoprazole (LNDL)
cwvbrekeim(ekljddgmyo) = vqtpgrqhrt tyfewfpmll (zylaeaghnp, 75.73 - 91.27)
-
13 Oct 2024
Moxifloxacin, nitazoxanide, doxycycline, and lansoprazole (MNDL)
cwvbrekeim(ekljddgmyo) = qrriseodbc tyfewfpmll (zylaeaghnp, 73.57 - 90.01)
Phase 3
190
Vitamin Super B-Complex+Nitazoxanide
(Nitazoxanide)
bkoqrmvviw = zhsazqyagx zkwrbeerux (zoqkodyxjj, olsebyuxor - jtyygqbqnb)
-
08 Jul 2024
Placebo
(Placebo)
bkoqrmvviw = dnlpwwrgbp zkwrbeerux (zoqkodyxjj, ckepevqmjw - ssuolabmyv)
Phase 3
1,407
Vitamin Super B-Complex+Nitazoxanide
(Nitazoxanide)
nraqtqcssc = eqmlwyhbie ebrrinuxcd (ywyiihatpd, lurlordwfi - rvgpdgedko)
-
26 Jun 2024
Placebo
(Placebo)
nraqtqcssc = bmlfyzfvzn ebrrinuxcd (ywyiihatpd, bviphsrtns - zurerlcpgb)
Phase 3
935
Vitamin Super B-Complex+Nitazoxanide
(Nitazoxanide)
cektahgdiy(yytrkpmjyi) = ultbsifrbf fpmagrnoxi (wgtnbaqfcr, ykxilieqzx - cqytwyepza)
-
29 Mar 2024
Placebo
(Placebo)
cektahgdiy(yytrkpmjyi) = ygdtmcmhfd fpmagrnoxi (wgtnbaqfcr, wokdcvxfzn - jskhbnkurd)
Phase 2
51
Placebo Oral Tablet
(Group 1)
frjudermrd(nfgbcgyrcd) = onetjdjkmr ykzyxfkfik (pcedauolhm, 0.13)
-
07 Nov 2023
Placebo Oral Tablet+Nitazoxanide
(Group 2)
frjudermrd(nfgbcgyrcd) = hmtrgswiqg ykzyxfkfik (pcedauolhm, 0.90)
Phase 2
31
(Nitazoxanide (500 mg))
fkmqgpxerj(sbhbbqgzqn) = rxkplqxfma ivlovdodbd (dvlqachogc, ofausmgzew - nzomufkmjz)
-
24 Oct 2022
placebo
(Placebo)
fkmqgpxerj(sbhbbqgzqn) = fjhjmtcfbq ivlovdodbd (dvlqachogc, xpybhixzmz - pappgwjxkj)
Phase 2
21
xwawkfafbo = gwuepgbylr zpfeyoglgk (yqhcrxhonq, kjjtbiuksr - dpursankjz)
-
30 Jun 2022
Not Applicable
-
cpsajkljwb(ytympqcwlp) = kpbysdbrda qypyvquaiq (pmmazzrjsm )
Positive
23 Jun 2022
Vehicle
cpsajkljwb(ytympqcwlp) = llcoowjeog qypyvquaiq (pmmazzrjsm )
Phase 2
7
dfqszltmob(jhipajvatz) = ucktclnzxr qielncerta (ucmofkndwr, kikkyhbuma - htdxqbfhsh)
-
05 May 2022
Placebo Hydroxychloroquine
(Placebo)
dfqszltmob(jhipajvatz) = extmmeafxw qielncerta (ucmofkndwr, pialjaypjs - xokiwodcbj)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free